Ex vivo drug screening on patient-derived tumor material to advance functional precision in oncology: an overview on current approaches and unresolved challenges
Cancer Treatment Reviews · 2026-02 · 143 · 103072
DOI: 10.1016/j.ctrv.2025.103072 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cancer Treatment Reviews, 2026-02. Verfasst von Zoltán Spiró und 9 weiteren Autor:innen. Beteiligte Einrichtung: Division of Oncology, Department of Medicine I, Medical University of Vienna, Vienna, Austria; Precision Medicine Technologies, CBmed GmbH, Graz, Aus…. Hauptthemen laut MEDLINE: Precision Medicine, Neoplasms, Antineoplastic Agents. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 73 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Bundesministerium Bildung, Ludwig Boltzmann Research Network.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Oncology, Department of Medicine I, Medical University of Vienna, Vienna, Austria; Precision Medicine Technologies, CBmed GmbH, Graz, Austria. Electronic address: zoltan.spiro@meduniwien.ac.at.
- Gottfried Schatz Research Center, Division of Cell Biology, Histology and Embryology, Medical University of Graz, Graz, Austria.
- Division of Oncology, Department of Medicine I, Medical University of Vienna, Vienna, Austria.
- Precision Medicine Technologies, CBmed GmbH, Graz, Austria.
- Department of Neurosurgery, Johannes Kepler University, Linz, Kepler University Hospital Linz, Linz, Austria; Clinical Research Institute for Neurosciences, Johannes Kepler University and Kepler University Hospital Linz…
- Department of Pathology, Neuropathology and Molecular Pathology, Medical University of Innsbruck, Innsbruck, Austria.
Förderung
- Bundesministerium Bildung
- Ludwig Boltzmann Research Network
Zitieren
APA
Spiró, Z., El-Heliebi, A., Mair, M. J., Pieber, T. R., Prietl, B., Spiegl-Kreinecker, S., Stanzer, S., Wöhrer, A., Preusser, M., & Berghoff, A. S. (2026). Ex vivo drug screening on patient-derived tumor material to advance functional precision in oncology: an overview on current approaches and unresolved challenges. Cancer Treatment Reviews, 143, 103072. https://doi.org/10.1016/j.ctrv.2025.103072
Vancouver
Spiró Z, El-Heliebi A, Mair MJ, Pieber TR, Prietl B, Spiegl-Kreinecker S, et al. Ex vivo drug screening on patient-derived tumor material to advance functional precision in oncology: an overview on current approaches and unresolved challenges. Cancer Treatment Reviews. 2026;143:103072. doi:10.1016/j.ctrv.2025.103072
BibTeX
@article{Spir2026,
author = {Spiró, Zoltán and El-Heliebi, Amin and Mair, Maximilian J and Pieber, Thomas R and Prietl, Barbara and Spiegl-Kreinecker, Sabine and Stanzer, Stefanie and Wöhrer, Adelheid and Preusser, Matthias and Berghoff, Anna Sophie},
title = {Ex vivo drug screening on patient-derived tumor material to advance functional precision in oncology: an overview on current approaches and unresolved challenges},
journal = {Cancer Treatment Reviews},
year = {2026},
volume = {143},
pages = {103072},
doi = {10.1016/j.ctrv.2025.103072}
}
EUVIMED